Cadila Healthcare has informed that the Company enclosed a Press Release dated May 16, 2020 titled ‘Zydus Cadila receives tentative approval from USFDA for Droxidopa Capsules, 100 mg, 200 mg, and 300 mg’.
The above information is a part of company’s filings submitted to BSE.